Institutional Ownership Vera Therapeutics, Inc. (VERA)
This table provides information about the institutional ownership of Vera Therapeutics, Inc. (VERA). We have compiled data on the 193 institutions that hold shares in the stock, with a total of 63.9 Million shares, which have been reported (via 13F filing form) to have a value of $1.89 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Avoro Capital Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
5,610,000
shares
|
$166 Million
3.46% of portfolio
|
Q4 2024
Added 30.17%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
4,377,049
shares
|
$130 Million
0.02% of portfolio
|
Q4 2024
Added 11.12%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,337,672
shares
|
$98.8 Million
0.0% of portfolio
|
Q2 2024
Added 0.56%
|
|
|
Abingworth LLP
London, X0 |
Feb 10, 2023 Q4 2022 |
2,960,231
shares
|
$87.7 Million
19.0% of portfolio
|
Q2 2021
New holding
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
2,949,564
shares
|
$87.3 Million
0.0% of portfolio
|
Q4 2024
Added 14.32%
|
|
|
Sofinnova Investments, Inc.
Menlo Park, CA |
Feb 14, 2025 Q4 2024 |
2,793,987
shares
|
$82.7 Million
9.63% of portfolio
|
Q4 2023
Added 24.09%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
2,026,352
shares
|
$60 Million
0.0% of portfolio
|
Q4 2024
Added 11.11%
|
|
|
Commodore Capital LP
New York, NY |
Feb 14, 2025 Q4 2024 |
1,958,600
shares
|
$58 Million
8.3% of portfolio
|
Q4 2024
Reduced 20.86%
|
|
|
Holocene Advisors, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
1,875,963
shares
|
$55.5 Million
0.27% of portfolio
|
Q4 2024
Reduced 4.02%
|
|
|
Samlyn Capital, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
1,662,220
shares
|
$49.2 Million
1.13% of portfolio
|
Q4 2024
Added 22.29%
|
|
|
Eversept Partners, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
1,600,015
shares
|
$47.4 Million
6.83% of portfolio
|
Q4 2024
Reduced 21.96%
|
|
|
Kynam Capital Management, LP
Princeton, NJ |
Feb 14, 2025 Q4 2024 |
1,457,910
shares
|
$43.2 Million
3.91% of portfolio
|
Q4 2024
Reduced 7.53%
|
|
|
Paradigm Biocapital Advisors LP
New York, NY |
Feb 14, 2025 Q4 2024 |
1,437,339
shares
|
$42.6 Million
2.32% of portfolio
|
Q4 2024
Added 31.04%
|
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
1,415,179
shares
|
$41.9 Million
0.04% of portfolio
|
Q4 2024
Added 43.82%
|
|
|
First Light Asset Management, LLC
Edina, MN |
Feb 14, 2025 Q4 2024 |
1,261,246
shares
|
$37.3 Million
5.22% of portfolio
|
Q4 2024
Added 78.84%
|
|
|
Woodline Partners LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
1,202,466
shares
|
$35.6 Million
0.38% of portfolio
|
Q4 2024
Added 20.14%
|
|
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
Feb 14, 2025 Q4 2024 |
1,153,670
shares
|
$34.2 Million
0.15% of portfolio
|
Q4 2024
Added 170.81%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
1,153,325
shares
|
$34.1 Million
0.0% of portfolio
|
Q4 2024
Added 14.8%
|
|
|
Integral Health Asset Management, LLC
|
Feb 14, 2025 Q4 2024 |
1,150,000
shares
|
$34.1 Million
4.35% of portfolio
|
Q4 2024
Added 130.0%
|
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Feb 13, 2025 Q4 2024 |
1,085,986
shares
|
$32.2 Million
0.11% of portfolio
|
Q4 2024
Added 162.25%
|
|
|
Vestal Point Capital, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
1,075,000
shares
|
$31.8 Million
2.7% of portfolio
|
Q4 2024
New holding
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
919,352
shares
|
$27.2 Million
0.02% of portfolio
|
Q2 2023
New holding
|
|
|
Logos Global Management LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
875,000
shares
|
$25.9 Million
4.86% of portfolio
|
Q4 2024
Added 75.0%
|
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Feb 12, 2025 Q4 2024 |
841,313
shares
|
$24.9 Million
0.04% of portfolio
|
Q4 2024
Added 47.08%
|
|
|
Marshall Wace, LLP
London, X0 |
Feb 13, 2025 Q4 2024 |
837,146
shares
|
$24.8 Million
0.05% of portfolio
|
Q4 2024
Added 43.41%
|